Results 91 to 100 of about 7,473 (181)

BLyS/APRIL dual inhibition by telitacicept for refractory pemphigus vulgaris combined with hepatocellular cancer. [PDF]

An Bras Dermatol
Chen W, Xu J, Zhang Y.
europepmc   +1 more source

Rituximab resistant pemphigus vulgaris successfully treated with obinutuzumab. [PDF]

JAAD Case Rep
Hiel MAJ, Diercks GFH, Bolling MC, Bremer J, Meijer JM, Horváth B.   +5 more
europepmc   +1 more source

Protocol for evaluating the effects of the intelligent multimodal symptom assessment and response system in patients with pemphigus vulgaris: a randomised controlled trial. [PDF]

BMJ Open
Chen Y, Wang L, Gao J, Xiao R, Yan S, Pan X, Yu Y, Yuan C, Yuan Y.   +8 more
europepmc   +1 more source

Extensive cutaneous involvement in pemphigus vulgaris in a pediatric patient: a rare clinical image. [PDF]

Pan Afr Med J
Vihirkar S, Wankhede DK.
europepmc   +1 more source

A case of juvenile pemphigus vulgaris effectively treated with dupilumab. [PDF]

JAAD Case Rep
Maruschak-Love S, Kost G, Mahmood MN, Sánchez-Espino LF.   +3 more
europepmc   +1 more source

Isolated perineal plaque as the initial presentation of pemphigus vulgaris. [PDF]

JAAD Case Rep
Workineh A, Panse G, Tomayko M, Little AJ.   +3 more
europepmc   +1 more source

Pemphigus Vulgaris With an Elevated Faecal Calprotectin Mimicking Inflammatory Bowel Disease: A Case Report. [PDF]

Cureus
Abdullah A, Bertfield D, Chan C.
europepmc   +1 more source

Dihydroartemisinin attenuates pemphigus vulgaris by regulating Dsg3 and the TLR9/NF-κB pathway. [PDF]

Am J Transl Res
Cui Y, Song S, Cheng Y, Hu C, Yang M, Wang W.   +5 more
europepmc   +1 more source

Penile erosions: an atypical initial manifestation of pemphigus vulgaris. [PDF]

An Bras Dermatol
Leme HJ, Ramos J, Magarreiro-Silva A, Gouveia AI, Alves J.   +4 more
europepmc   +1 more source

Comparing the genetic and serum expression of LL-37 Antimicrobial Peptide in pemphigus vulgaris and pemphigus foliaceus patients. [PDF]

An Bras Dermatol
Dhaffouli F, Elloumi N, Sellami K, Bahloul E, Tahri S, Turki H, Hachicha H, Abida O.   +7 more
europepmc   +1 more source